Cardiothoracic & vascular anesthesia
Erector spinae plane block for postoperative analgesia in robotically-assisted coronary artery bypass surgery: Results of a randomized placebo-controlled trial
Authors' conclusion
Following RAMIDCAB surgery, adding an ESP block to a standard multimodal analgesia regimen did not reduce opioid consumption and pain scores.
Study context
- Population
- Patients undergoing RAMIDCAB surgery via left-sided mini-thoracotomy in an enhanced recovery after cardiac surgery program
- Participants
- 64 patients
- Comparison
- Ropivacaine vs Normal saline
- Primary endpoint
- Cumulative morphine consumption
- Follow-up
- First 24 h after extubation
Methodological detailssingle-centre, double-blind, prospective, placebo-controlled
- Single-centre
- Double-blind
- Prospective
- Placebo-controlled
Primary result
As reported in the abstract
Cumulative morphine consumption in the first 24 h after extubation · 24 h
- Ropivacaine vs Normal saline: P = 0.25
- Ropivacaine = intervention group; Normal saline = control group
Secondary outcomes
Location and severity of pain, sensory block, duration of postoperative ventilation, hospital LOS
- No differences detected
Safety
Incidence of adverse events
- No differences detected
Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.
Original publication
Erector spinae plane block for postoperative analgesia in robotically-assisted coronary artery bypass surgery: Results of a randomized placebo-controlled trial. J Clin Anesth. Published 1 March 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →